| Application no. and date | 10729901.8 (espacenet) (Federated) (European Patent Register), 20100708 | | Patent/reg. no. and date | DK/EP 2451797, 20130403 | | Publication date | 20120516 | | Priority no. and date | EP 09165125, 20090710 | | EP pub. no. and date |
EP 2451797 20120516 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica, N.V., Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | JANS PRD3094-PCT-EPO | | Inventor | RAMMELOO, Thomas Joachim Landewald, Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE,
DE KEYSER, Ruben, Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE,
SCHILDERMANS, Gustaaf Jozef Petrus, Janssen Pharmaceutica NV
Turnhoutseweg 30
B-2340 Beerse, BE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 309/10 (2006.01) | | Title | Fremgangsmåde til krystallisation for 1-(b-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-fluorphenyl)-2- thienylmethyl]benzen | | Int. application no. | EP2010059817 | | Int. publication no. | WO2011003976 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
